Archive · 8 Aug 2025
Researchers Rush to Develop Measles Treatments Amid Rising Cases
Measles cases are going up because fewer people are getting vaccinated.
Because of this, scientists are trying to find new ways to treat measles.
They are working on special drugs that could help people who are already sick or who can't get vaccinated.
Some people are worried that if there are treatments, people may be less likely to get vaccinated.
It's like scientists are creating new medicine for a disease that was mostly under control, because the old methods aren't working as well anymore.
Scientists are racing to develop treatments for measles as cases surge in the U.S.
Vaccination rates have fallen, leading to a rise in measles infections, with over 1,300 cases this year.
Researchers are exploring monoclonal antibodies and antiviral drugs as potential treatments.
Some doctors are skeptical of the MMR vaccine's safety, and some patients prefer treatment options.
Development of measles treatments may cause further decline in vaccination rates, according to some.
- Who
- Scientists and researchers from institutions like Invivyd, Saravir Biopharma, Vanderbilt University, and Georgia State University are working on treatments.
- What
- Researchers are developing treatments for measles.
- When
- Now, as infections rise due to decreased vaccination rates.
- Where
- Across the U.S., with research happening in various universities and biotech companies.
- Why
- To prevent or treat measles in vulnerable and unvaccinated people due to rising infection rates and declining vaccination rates.
Vaccination Skeptics
Public Health Officials
Vaccine Safety Concerns
Vaccination Skeptics
Some doctors express concerns regarding the lack of adequate safety data for the MMR vaccine.
Public Health Officials
Health authorities emphasize the MMR vaccine's safety and effectiveness.
Approach to Prevention
Vaccination Skeptics
Some doctors and patients favor treatment options as alternatives to vaccination.
Public Health Officials
The CDC recommends the MMR shot as the primary prevention method.
- Measles Cases in 2024
- Over 1,300, a 33-year high
- MMR Vaccination Rate (2024)
- 92.5% of kindergartners
- Previous MMR Vaccination Rate (2019-2020)
- Over 95%
- Focus of Treatments
- Monoclonal antibodies and antiviral drugs
- Antibody Protection Duration
- Weeks or months